Tuesday, February 16, 1993
NIH readies deal inquiry
WASHINGTON -- The NIH has decided to investigate licensing
agreements between the top NIH-funded non-profit research institutions and private
companies in response to a congressional inquiry into the pricing of drugs developed
using federally subsidized research.
The NIH last week still was developing a list of 20-25 grantees,
which include the major research universities, from which to request information
on co-development arrangements, said agency spokeswoman Joanna Snyder.